Literature DB >> 8181786

Production of enterotoxin, verotoxin, hemolysin and cytotoxic necrotizing factor by Escherichia coli of intestinal and extraintestinal origin.

A Hostacká1.   

Abstract

Seventy-six Escherichia coli strains were examined for heat-labile enterotoxin (LT), verotoxin (VT), hemolysin (HLy) and cytotoxic necrotizing factor (CNF). Thirty-six strains were isolated from patients suffering from diarrhea and forty from different extraintestinal infections. The number of LT-producing strains was low (2.6%) (one of intestinal and one of extraintestinal origin). Verotoxin was produced only by one extraintestinal strain. Four intestinal strains were hemolytic (11.2%) and also positive for CNF. From 24 hemolytic strains of extraintestinal origin (60%), 17 produced also CNF. Most of the hemolytic (30%) as well as CNF-producing strains (22.5%) were isolated from urine. Our results are similar to those of other studies confirming the close association between hemolysin and CNF production as well as a possible role of these toxic factors in pathogenesis of extraintestinal infections caused by E. coli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181786     DOI: 10.1007/BF02814536

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  20 in total

1.  Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome.

Authors:  I Luzzi; F Minelli; A Gianviti; A Caprioli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  [Microbiological aspects of infection with verotoxin-producing E. coli strains in children with the hemolytic-uremic syndrome].

Authors:  M Bielaszewská; J Janda
Journal:  Cesk Epidemiol Mikrobiol Imunol       Date:  1989-07

3.  Detection of heat-labile enterotoxins of Escherichia coli using the Biken test.

Authors:  J A Wigmore
Journal:  Med Lab Sci       Date:  1984-04

4.  Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome.

Authors:  F Gunzer; H Böhm; H Rüssmann; M Bitzan; S Aleksic; H Karch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

5.  Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections.

Authors:  A Caprioli; V Falbo; F M Ruggeri; L Baldassarri; R Bisicchia; G Ippolito; E Romoli; G Donelli
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

6.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis.

Authors:  A P Burnens; P Boss; F Orskov; I Orskov; U B Schaad; F Müller; R Heinzle; J Nicolet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 8.  Escherichia coli cytotoxins and enterotoxins.

Authors:  C L Gyles
Journal:  Can J Microbiol       Date:  1992-07       Impact factor: 2.419

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 10.  Classification of pathogenic Escherichia coli according to serotype and the production of virulence factors, with special reference to colonization-factor antigens.

Authors:  D J Evans; D G Evans
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct
View more
  2 in total

1.  Effect of Escherichia coli cytotoxic necrotizing factor 1 on repair of human bladder cell monolayers in vitro.

Authors:  M D Island; X Cui; J W Warren
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Cytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells.

Authors:  M D Island; X Cui; B Foxman; C F Marrs; W E Stamm; A E Stapleton; J W Warren
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.